• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺和肺神经内分泌肿瘤的危险因素:病例对照研究。

Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control study.

机构信息

Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Roma, Italia.

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

出版信息

Endocrine. 2021 Jan;71(1):233-241. doi: 10.1007/s12020-020-02464-5. Epub 2020 Aug 31.

DOI:10.1007/s12020-020-02464-5
PMID:32869113
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7835148/
Abstract

PURPOSE

Neuroendocrine neoplasia (NEN) has been displaying an incremental trend along the last two decades. This phenomenon is poorly understood, and little information is available on risk factor for neuroendocrine neoplasia development. Aim of this work is to elucidate the role of potentially modifiable risk factors for pancreatic and pulmonary NEN.

METHODS

We conducted a case-control study on 184 patients with NEN (100 pancreas and 84 lung) and 248 controls. The structured questionnaire included 84 queries on socio-demographic, behavioral, dietary and clinical information.

RESULTS

Increased risk was associated with history of cancer ("other tumor", lung OR = 7.18; 95% CI: 2.55-20.20 and pancreas OR = 5.88; 95% CI: 2.43-14.22; "family history of tumor", lung OR = 2.66; 95% CI: 1.53-4.64 and pancreas OR = 1.94; 95% CI: 1.19-3.17; "family history of lung tumor", lung OR = 2.56; 95% CI: 1.05-6.24 and pancreas OR = 2.60; 95% CI: 1.13-5.95). Type 2 diabetes mellitus associated with an increased risk of pancreatic NEN (OR = 3.01; 95% CI: 1.15-7.89).

CONCLUSIONS

Besides site-specific risk factors, there is a significant link between neuroendocrine neoplasia and cancer in general, pointing to a shared cancer predisposition.

摘要

目的

神经内分泌肿瘤(NEN)在过去二十年中呈现出递增趋势。这种现象尚未被充分理解,有关神经内分泌肿瘤发展的危险因素的信息也很少。本研究旨在阐明胰腺和肺神经内分泌肿瘤的潜在可改变危险因素的作用。

方法

我们对 184 名 NEN 患者(100 名胰腺和 84 名肺)和 248 名对照进行了病例对照研究。结构化问卷包括 84 个关于社会人口统计学、行为、饮食和临床信息的问题。

结果

癌症史(“其他肿瘤”,肺 OR=7.18;95%CI:2.55-20.20 和胰腺 OR=5.88;95%CI:2.43-14.22;“肿瘤家族史”,肺 OR=2.66;95%CI:1.53-4.64 和胰腺 OR=1.94;95%CI:1.19-3.17;“肺癌家族史”,肺 OR=2.56;95%CI:1.05-6.24 和胰腺 OR=2.60;95%CI:1.13-5.95)与风险增加相关。2 型糖尿病与胰腺 NEN 的风险增加相关(OR=3.01;95%CI:1.15-7.89)。

结论

除了特定部位的危险因素外,神经内分泌肿瘤与一般癌症之间存在显著关联,表明存在共同的癌症易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee97/7835148/841a21e3d740/12020_2020_2464_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee97/7835148/841a21e3d740/12020_2020_2464_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee97/7835148/841a21e3d740/12020_2020_2464_Fig1_HTML.jpg

相似文献

1
Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control study.胰腺和肺神经内分泌肿瘤的危险因素:病例对照研究。
Endocrine. 2021 Jan;71(1):233-241. doi: 10.1007/s12020-020-02464-5. Epub 2020 Aug 31.
2
Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis.神经内分泌肿瘤的风险因素:系统评价和荟萃分析。
Ann Oncol. 2016 Jan;27(1):68-81. doi: 10.1093/annonc/mdv505. Epub 2015 Oct 20.
3
Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.与神经内分泌肿瘤相关的风险因素:一项基于美国的病例对照研究。
Int J Cancer. 2008 Aug 15;123(4):867-73. doi: 10.1002/ijc.23529.
4
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.胃肠胰神经内分泌肿瘤(GEP-NENs)的危险因素:一项三中心病例对照研究。
J Endocrinol Invest. 2022 Apr;45(4):849-857. doi: 10.1007/s40618-021-01715-0. Epub 2022 Jan 18.
5
Neuroendocrine neoplasms of lung, pancreas and gut: a morphology-based comparison.肺、胰腺和肠道神经内分泌肿瘤:基于形态学的比较。
Endocr Relat Cancer. 2020 Nov;27(11):R417-R432. doi: 10.1530/ERC-20-0122.
6
Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm.线粒体DNA置换环区域序列多态性作为胃肠胰神经内分泌肿瘤危险因素的鉴定
J Clin Lab Anal. 2017 Sep;31(5). doi: 10.1002/jcla.22078. Epub 2016 Oct 5.
7
Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England.英国神经内分泌肿瘤患者的第二原发恶性肿瘤。
Neuroendocrinology. 2023;113(8):811-821. doi: 10.1159/000530238. Epub 2023 Mar 20.
8
How should incidental NEN of the pancreas and gastrointestinal tract be followed?胰腺和胃肠道偶发神经内分泌肿瘤应如何随访?
Rev Endocr Metab Disord. 2018 Jun;19(2):139-144. doi: 10.1007/s11154-018-9445-4.
9
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.日本胃-肠-胰神经内分泌肿瘤(GEP-NEN)患者的最新流行病学:一项基于人群的研究。
BMC Cancer. 2020 Nov 14;20(1):1104. doi: 10.1186/s12885-020-07581-y.
10
Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.胃肠胰神经内分泌肿瘤:单中心10年经验
Pol Arch Med Wewn. 2015;125(5):337-46. doi: 10.20452/pamw.2832. Epub 2015 Apr 29.

引用本文的文献

1
Basic science and translational implications of current knowledge on neuroendocrine tumors.当前神经内分泌肿瘤知识的基础科学及转化意义
J Clin Invest. 2025 Mar 3;135(5):e186702. doi: 10.1172/JCI186702.
2
Discordant risk factors between pancreatic neuroendocrine neoplasms and pancreatic ductal adenocarcinoma.胰腺神经内分泌肿瘤与胰腺导管腺癌之间不一致的危险因素。
Endocr Relat Cancer. 2025 Mar 1;32(4). doi: 10.1530/ERC-24-0142. Print 2025 Apr 1.
3
Nutritional status and gastroenteropancreatic neuroendocrine neoplasms: lights and shadows with a clinical guide from the NIKE Group.

本文引用的文献

1
The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report.Li-Fraumeni 综合征中首例胰腺神经内分泌肿瘤:病例报告。
BMC Cancer. 2020 Mar 30;20(1):256. doi: 10.1186/s12885-020-06723-6.
2
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
3
Pan-cancer whole-genome analyses of metastatic solid tumours.泛癌种实体瘤全基因组分析。
营养状况与胃肠胰神经内分泌肿瘤:耐克集团临床指南中的亮点与难点
Rev Endocr Metab Disord. 2025 Apr;26(2):161-174. doi: 10.1007/s11154-024-09937-2. Epub 2024 Dec 9.
4
Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.二甲双胍与胰腺神经内分泌肿瘤:系统评价和荟萃分析。
World J Gastroenterol. 2024 Feb 21;30(7):759-769. doi: 10.3748/wjg.v30.i7.759.
5
Site-specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany.德国巴伐利亚胃肠胰神经内分泌肿瘤的部位特异性趋势。
Cancer Med. 2023 Oct;12(19):19949-19958. doi: 10.1002/cam4.6510. Epub 2023 Sep 22.
6
Perioperative Carcinoid Crisis: A Systematic Review and Meta-Analysis.围手术期类癌危象:一项系统评价与荟萃分析。
Cancers (Basel). 2022 Jun 16;14(12):2966. doi: 10.3390/cancers14122966.
7
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control study.胃肠胰神经内分泌肿瘤(GEP-NENs)的危险因素:一项三中心病例对照研究。
J Endocrinol Invest. 2022 Apr;45(4):849-857. doi: 10.1007/s40618-021-01715-0. Epub 2022 Jan 18.
Nature. 2019 Nov;575(7781):210-216. doi: 10.1038/s41586-019-1689-y. Epub 2019 Oct 23.
4
Metachronous and Synchronous Cancers in Patients with Neuroendocrine Tumors.神经内分泌肿瘤患者的异时性和同时性癌症。
Oncology. 2020;98(1):10-15. doi: 10.1159/000502384. Epub 2019 Sep 10.
5
Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.WHO 2010 版与 WHO 2017 版胰腺神经内分泌肿瘤分级的竞争测试:来自大型国际队列研究的数据。
Neuroendocrinology. 2018;107(4):375-386. doi: 10.1159/000494355. Epub 2018 Oct 9.
6
Management and Follow-up of Patients with a Bronchial Neuroendocrine Tumor in the Last Twenty Years in Ireland: Expected Inconsistencies and Unexpected Discoveries.爱尔兰过去二十年支气管神经内分泌肿瘤患者的管理与随访:预期的不一致性与意外的发现
Int J Endocrinol. 2018 Aug 29;2018:1043287. doi: 10.1155/2018/1043287. eCollection 2018.
7
A germline mutation is associated with small intestinal neuroendocrine tumors.种系突变与小肠神经内分泌肿瘤相关。
Endocr Relat Cancer. 2017 Aug;24(8):427-443. doi: 10.1530/ERC-17-0196. Epub 2017 Jun 20.
8
Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.散发性胰腺内分泌肿瘤发生的风险和保护因素。
Endocr Relat Cancer. 2017 Aug;24(8):405-414. doi: 10.1530/ERC-17-0040. Epub 2017 May 31.
9
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
10
Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms.神经内分泌肿瘤低级别和高级别发病率呈上升趋势。
Endocrine. 2017 Nov;58(2):368-379. doi: 10.1007/s12020-017-1273-x. Epub 2017 Mar 16.